News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Levothyroxine offers no cardiometabolic benefits in older adults with subclinical hypothyroidism
Just Now
byStephen Padilla
Treatment with levothyroxine does not yield clear effects on cardiometabolic biomarkers in older adults with subclinical hypothyroidism, according to a study. However, individuals with baseline thyroid-stimulating hormone (TSH) ≥10 mIU/L show potentially favourable changes in lipids and lipoproteins.
Levothyroxine offers no cardiometabolic benefits in older adults with subclinical hypothyroidism
Just Now
SUNRISE supports tezepelumab in severe OCS-dependent asthma
a day ago
byAudrey Abella
In the phase III SUNRISE trial, tezepelumab significantly reduces daily maintenance oral corticosteroid (OCS) dose while maintaining asthma control in adults with severe OCS-dependent asthma, despite early study termination and the smaller-than-planned sample size.







